Business
AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that the Company will present at the 44th Annual J.P. Morgan
About this update from Abcellera Biologics Inc.
VANCOUVER, British Columbia --(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that the Company will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 . A live audio webcast of the presentation may be accessed through a link that will be posted on AbCellera's Investor Relations website . A replay will be available through the same link following the presentation. About AbCellera Biologics Inc . AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visit www.abcellera.com . View source version on businesswire.com : https://www.businesswire.com/news/home/20251208404823/en/ Inquiries Media: Tiffany Chiu ; [email protected] , +1(236)521-6774 Partnering: Murray McCutcheon , Ph.D.; [email protected] , +1(604)559-9005 Investor Relations: Peter Ahn ; [email protected] , +1(778)729-9116 Source: AbCellera Biologics Inc.
View stock analysis, news, and events for Abcellera Biologics Inc.